Beneficial effect of polaprezinc on cardiac function post-myocardial infarction: A prospective and randomized clinical trial

BACKGROUND: Polaprezinc is clinically used for the treatment of gastric ulcers. It induces the mobilization of mesenchymal stem cells and the mRNA expression of insulin-like growth factor-1 in vascular endothelial cells in order to protect injured gastric tissue or skin. METHODS: The current study p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshikawa, Fumitsugu, Nakajima, Tetsu, Hanada, Masaharu, Hirata, Kazuo, Masuyama, Tohru, Aikawa, Ryuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417532/
https://www.ncbi.nlm.nih.gov/pubmed/30855449
http://dx.doi.org/10.1097/MD.0000000000014637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417532/
https://www.ncbi.nlm.nih.gov/pubmed/30855449
http://dx.doi.org/10.1097/MD.0000000000014637

Ejemplares similares